OAM
GILD icon

Oxford Asset Management’s Gilead Sciences GILD Stock Holding History

Oxford Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$942K Buy
7,457
+2,713
+57% +$357K 0.46% 46
2026
Q1 		$661K Buy
4,744
+2,028
+75% +$284K 0.27% 111
2025
Q4 		$333K Sell
2,716
-7,267
-73% -$883K 0.12% 275
2025
Q3 		$1.11M Buy
9,983
+3,449
+53% +$392K 0.36% 68
2025
Q2 		$724K Sell
6,534
-682
-9% -$72.6K 0.24% 114
2025
Q1 		$809K Buy
+7,216
New +$745K 0.37% 62
2024
Q2 		– Sell
-8,404
Closed -$616K – 336
2024
Q1 		$616K Buy
8,404
+3,856
+85% +$297K 0.64% 43
2023
Q4 		$368K Buy
+4,548
New +$354K 0.55% 64
2020
Q1 		$204K Sell
2,728
-203,708
-99% -$14.1M 0.03% 114
2019
Q4 		$13.4M Buy
206,436
+41,950
+26% +$2.73M 0.37% 35
2019
Q3 		$10.4M Sell
164,486
-28,666
-15% -$1.87M 0.25% 79
2019
Q2 		$13M Buy
193,152
+41,216
+27% +$2.71M 0.28% 50
2019
Q1 		$9.88M Buy
151,936
+2,203
+1% +$146K 0.22% 91
2018
Q4 		$9.37M Buy
149,733
+89,864
+150% +$6.28M 0.24% 81
2018
Q3 		$4.59M Sell
59,869
-85,641
-59% -$6.47M 0.1% 249
2018
Q2 		$10.3M Buy
145,510
+137,973
+1,831% +$9.74M 0.2% 88
2018
Q1 		$568K Sell
7,537
-3,782
-33% -$301K 0.01% 1190
2017
Q4 		$811K Buy
11,319
+3,254
+40% +$247K 0.02% 1019
2017
Q3 		$644K Buy
+8,065
New +$617K 0.01% 1110
2015
Q4 		– Sell
-55,762
Closed -$5.47M – 901
2015
Q3 		$5.47M Sell
55,762
-68,542
-55% -$7.61M 0.17% 114
2015
Q2 		$14.6M Sell
124,304
-1,624
-1% -$177K 0.39% 38
2015
Q1 		$12.4M Buy
125,928
+100,881
+403% +$10.2M 0.31% 53
2014
Q4 		$2.38M Sell
25,047
-130,649
-84% -$13.5M 0.05% 344
2014
Q3 		$16.6M Buy
+155,696
New +$15.2M 0.38% 37
2014
Q2 		– Sell
-90,468
Closed -$6.41M – 727
2014
Q1 		$6.41M Buy
90,468
+79,590
+732% +$6.24M 0.19% 174
2013
Q4 		$817K Buy
+10,878
New +$757K 0.02% 540

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oxford Asset Management's GILD Position: Q2 2026 in Review

Oxford Asset Management increased its Gilead Sciences (GILD) stake by 57% in Q2 2026, buying an estimated $357K and bringing the position to 7,457 shares worth $942K. The position accounts for 0.46% of the portfolio, ranked #46.

Oxford Asset Management first reported a position in GILD in Q4 2013 and has held it in 26 quarters since. The position peaked at $16.6M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Oxford Asset Management held 7,457 shares of Gilead Sciences worth $942K as of Q2 2026.
  • Oxford Asset Management bought 2,713 Gilead Sciences shares in Q2 2026, an estimated $357K.
  • Gilead Sciences made up 0.46% of Oxford Asset Management's portfolio in Q2 2026, its #46 holding.
  • Oxford Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 26 quarters since.
  • Oxford Asset Management's Gilead Sciences position peaked at $16.6M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.